Role of nutritional (PNI, CONUT) and inflammatory indices (SII) in predicting lymph node metastasis and prognosis of thyroid cancer: a systematic review and meta-analysis.
메타분석
1/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.7%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[PURPOSE] Markers reflecting systemic inflammation and nutritional condition are now often applied in predicting cancer outcomes, yet their role in thyroid malignancies has not been clearly establishe
- 95% CI 1.00-1.01
- HR 1.00
- 연구 설계 meta-analysis
APA
Liu Y, Xiao R (2026). Role of nutritional (PNI, CONUT) and inflammatory indices (SII) in predicting lymph node metastasis and prognosis of thyroid cancer: a systematic review and meta-analysis.. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. https://doi.org/10.1007/s00405-025-09976-8
MLA
Liu Y, et al.. "Role of nutritional (PNI, CONUT) and inflammatory indices (SII) in predicting lymph node metastasis and prognosis of thyroid cancer: a systematic review and meta-analysis.." European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026.
PMID
41634408 ↗
Abstract 한글 요약
[PURPOSE] Markers reflecting systemic inflammation and nutritional condition are now often applied in predicting cancer outcomes, yet their role in thyroid malignancies has not been clearly established. We reviewed the evidence in the literature on the role of Prognostic Nutritional Index (PNI), Controlling Nutritional Status Score (CONUT), and Systemic Immune-Inflammation Index (SII) in predicting lymph node metastasis (LNM), overall survival (OS), and disease-free survival (DFS) in thyroid cancer.
[METHODS] Two reviewers searched CENTRAL, Embase, PubMed, and Scopus databases till 24th August 2025 for relevant publications. A random-effects meta-analysis was conducted.
[RESULTS] Thirteen studies were eligible. Combined results demonstrated that elevated SII was slightly but significantly correlated with increased risk of LNM (HR: 1.00; 95% CI: 1.00-1.01; I² = 93%). Results failed to change in the sensitivity analysis. Subgroup analysis based on location and histology indicated non-significant results while meta-regression did not identify any significant moderators. Pooled analysis indicated no significant association between low PNI and DFS (HR: 1.45 95% CI: 0.97, 2.18 I2 = 80%) and LNM (HR: 1.31 95% CI: 0.89, 1.92 I2 = 73%) in thyroid cancer patients. Meta-analysis also showed that high CONUT was associated with a tendency of worse DFS in thyroid cancer, but results were non-significant (HR: 3.25 95% CI: 0.99, 10.69 I2 = 86%). However, meta-analysis showed that high CONUT was significantly associated with worse OS (HR: 9.67 95% CI: 1.90, 49.25 I2 = 61%).
[CONCLUSIONS] Limited data suggest that high SII may be marginally associated with increased risk of LNM in thyroid cancer, the clinical significance of which is questionable. PNI was not found to be associated with LNM or DFS in thyroid cancer patients. High CONUT was associated with poor OS and a non-significant tendency for worse DFS in thyroid cancer.
[METHODS] Two reviewers searched CENTRAL, Embase, PubMed, and Scopus databases till 24th August 2025 for relevant publications. A random-effects meta-analysis was conducted.
[RESULTS] Thirteen studies were eligible. Combined results demonstrated that elevated SII was slightly but significantly correlated with increased risk of LNM (HR: 1.00; 95% CI: 1.00-1.01; I² = 93%). Results failed to change in the sensitivity analysis. Subgroup analysis based on location and histology indicated non-significant results while meta-regression did not identify any significant moderators. Pooled analysis indicated no significant association between low PNI and DFS (HR: 1.45 95% CI: 0.97, 2.18 I2 = 80%) and LNM (HR: 1.31 95% CI: 0.89, 1.92 I2 = 73%) in thyroid cancer patients. Meta-analysis also showed that high CONUT was associated with a tendency of worse DFS in thyroid cancer, but results were non-significant (HR: 3.25 95% CI: 0.99, 10.69 I2 = 86%). However, meta-analysis showed that high CONUT was significantly associated with worse OS (HR: 9.67 95% CI: 1.90, 49.25 I2 = 61%).
[CONCLUSIONS] Limited data suggest that high SII may be marginally associated with increased risk of LNM in thyroid cancer, the clinical significance of which is questionable. PNI was not found to be associated with LNM or DFS in thyroid cancer patients. High CONUT was associated with poor OS and a non-significant tendency for worse DFS in thyroid cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Breast Morphological Comparison Between Anatomic and Round Implant Augmentation: A Prospective Study.
- Latent transforming growth factor beta binding protein 1 (LTBP1): roles as a multifunctional extracellular matrix regulator in human disease - from molecular mechanisms to clinical translation prospects.
- Association between body mass index and outcomes in lymphoma-associated haemophagocytic lymphohistiocytosis: A retrospective multicentre cohort study of Jiangsu Cooperative Lymphoma Group (JCLG).
- Single-cell and spatial transcriptome analysis of breast cancer tumor-associated fibroblast heterogeneity and its mediated remodeling of the tumor microenvironment.
- Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect.
- Nanotechnology-Assisted Molecular Profiling: Emerging Advances in Circulating Tumor DNA Detection.
- The role of disulfidptosis-driven tumor microenvironment remodeling in pancreatic cancer progression.
- SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics.
- Safe discharge on the second postoperative day after major colorectal surgery: a decision-making strategy based on quantitative serological data.